Jason Duncan, Chief Legal Officer and GC at ALBIREO PHARMA, INC. (ALBO), sold 657 shares at $24.68 ($16K) on 2022-07-22, disclosed to the SEC on 2022-07-25.
Scheduled sale ($16k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.45 | 238 | $6K | 36.6% |
| 2 | $24.68 | 106 | $3K | 16.4% |
| 3 | $23.66 | 220 | $5K | 32.7% |
| 4 | $24.40 | 93 | $2K | 14.3% |
| Total | $24.22 avg | 657 | $16K | 100% |
| Filing → |
| ALBO | SELL | 2022-10-25 | $13K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $22K | — | Filing → |
| ALBO | SELL | 2022-01-25 | $42K | — | Filing → |